Evidence map›Paper›PMID 36528821›Full record

ArticleArchivum immunologiae et therapiae experimentalis2022

Impact of Betamethasone Pretreatment on Engrafment of Cord Blood-Derived Hematopoietic Stem Cells.

David Perna-Barrull, Laia Gomez-Muñoz, Silvia Rodriguez-Fernandez, Anna Gieras, Rosa M Ampudia-Carrasco, Lidia Almenara-Fuentes, Ruth M Risueño, Sergi Querol, Eva Tolosa, Marta Vives-Pi

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Archivum immunologiae et therapiae experimentalis, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 2 countries.

David Perna-BarrullImmunology Department, Germans Trias I Pujol Research Institute, Autonomous University of Barcelona, Badalona, Spain.ORCID http://orcid.org/0000-0003-2079-818X
Laia Gomez-MuñozImmunology Department, Germans Trias I Pujol Research Institute, Autonomous University of Barcelona, Badalona, Spain.ORCID http://orcid.org/0000-0001-9640-6213
Silvia Rodriguez-FernandezImmunology Department, Germans Trias I Pujol Research Institute, Autonomous University of Barcelona, Badalona, Spain.ORCID http://orcid.org/0000-0001-8429-4293
Anna GierasDepartment of Immunology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.ORCID http://orcid.org/0000-0002-5147-2281
Rosa M Ampudia-CarrascoImmunology Department, Germans Trias I Pujol Research Institute, Autonomous University of Barcelona, Badalona, Spain.ORCID http://orcid.org/0000-0002-0734-0433
Lidia Almenara-FuentesAhead Therapeutics SL, Barcelona, Spain.ORCID http://orcid.org/0000-0002-8518-8078
Ruth M RisueñoJosep Carreras Leukaemia Research Institute, Campus IGTP-ICO, Badalona, Spain.ORCID http://orcid.org/0000-0003-4048-9536
Sergi QuerolCell Therapy Services and Cord Blood Bank, Catalan Blood and Tissue Bank, Barcelona, Spain.ORCID http://orcid.org/0000-0002-1105-8633
Eva TolosaDepartment of Immunology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.ORCID http://orcid.org/0000-0002-5247-8378
Marta Vives-PiImmunology Department, Germans Trias I Pujol Research Institute, Autonomous University of Barcelona, Badalona, Spain. mvives@igtp.cat.ORCID http://orcid.org/0000-0003-3735-0779
Universitat Autònoma de Barcelona · ESUniversität Hamburg · DEBanc de Sang i Teixits · ESJosep Carreras Leukaemia Research Institute · ES

Funding

Departament de Salut, Generalitat de Catalunya DI2021-69Departament de Salut, Generalitat de Catalunya SLT017/20/000049deutsche forschungsgemeinschaft KFO296
6 · The paper itself

Abstract

Hematopoietic stem cell (HSC) transplantation is crucial to cure hematologic malignancies. Umbilical cord blood (UCB) is a source of stem cells, but 90% of UCB units are discarded due to low cellularity. Improving the engraftment capacities of CD34

Indexed as

Cord Blood Stem Cell TransplantationHematopoietic Stem Cell TransplantationAnimalsAntigens, CD34BetamethasoneFetal BloodFluticasoneGlucocorticoidsHematopoietic Stem CellsMiceMice, Inbred NODMice, SCIDAntigens, CD34BetamethasoneFluticasoneGlucocorticoidsBetamethasoneCD34+Cord bloodHematopoietic stem cellImmune systemTransplantation

Identifiers

PMID36528821
PMCPMC9760591
OpenAlexW4312065985

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.